300 related articles for article (PubMed ID: 32750037)
21. Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis.
Diamond JM; Lederer DJ; Kawut SM; Lee J; Ahya VN; Bellamy S; Palmer SM; Lama VN; Bhorade S; Crespo M; Demissie E; Sonett J; Wille K; Orens J; Shah PD; Weinacker A; Weill D; Kohl BA; Deutschman CC; Arcasoy S; Shah AS; Belperio JA; Wilkes D; Reynolds JM; Ware LB; Christie JD;
Am J Transplant; 2011 Nov; 11(11):2517-22. PubMed ID: 21883907
[TBL] [Abstract][Full Text] [Related]
22. IL-1β-dependent extravasation of preexisting lung-restricted autoantibodies during lung transplantation activates complement and mediates primary graft dysfunction.
Yang W; Cerier EJ; Núñez-Santana FL; Wu Q; Yan Y; Kurihara C; Liu X; Yeldandi A; Khurram N; Avella-Patino D; Sun H; Budinger GRS; Kreisel D; Mohanakumar T; Lecuona E; Bharat A
J Clin Invest; 2022 Oct; 132(20):. PubMed ID: 36250462
[TBL] [Abstract][Full Text] [Related]
23. Pretransplant dyslipidaemia influences primary graft dysfunction after lung transplantation.
Cottini SR; Ehlers UE; Pagnamenta A; Brandi G; Weder W; Schuepbach RA; Béchir M; Benden C
Interact Cardiovasc Thorac Surg; 2016 Apr; 22(4):402-5. PubMed ID: 26718318
[TBL] [Abstract][Full Text] [Related]
24. Lung size mismatch and primary graft dysfunction after bilateral lung transplantation.
Eberlein M; Reed RM; Bolukbas S; Diamond JM; Wille KM; Orens JB; Brower RG; Christie JD;
J Heart Lung Transplant; 2015 Feb; 34(2):233-40. PubMed ID: 25447586
[TBL] [Abstract][Full Text] [Related]
25. Elevated donor plasminogen activator inhibitor-1 levels and the risk of primary graft dysfunction.
Hamilton BCS; Dincheva GR; Zhuo H; Golden JA; Brzezinski M; Singer JP; Matthay MA; Kukreja J
Clin Transplant; 2018 Apr; 32(4):e13210. PubMed ID: 29377268
[TBL] [Abstract][Full Text] [Related]
26. Plasma protein biomarkers for primary graft dysfunction after lung transplantation: a single-center cohort analysis.
Chacon-Alberty L; Kanchi RS; Ye S; Hochman-Mendez C; Daoud D; Coarfa C; Li M; Grimm SL; Baz M; Rosas I; Loor G
Sci Rep; 2022 Sep; 12(1):16137. PubMed ID: 36167867
[TBL] [Abstract][Full Text] [Related]
27. Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation.
Prekker ME; Nath DS; Walker AR; Johnson AC; Hertz MI; Herrington CS; Radosevich DM; Dahlberg PS
J Heart Lung Transplant; 2006 Apr; 25(4):371-8. PubMed ID: 16563963
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial damage-associated molecular patterns released by lung transplants are associated with primary graft dysfunction.
Scozzi D; Ibrahim M; Liao F; Lin X; Hsiao HM; Hachem R; Tague LK; Ricci A; Kulkarni HS; Huang HJ; Sugimoto S; Krupnick AS; Kreisel D; Gelman AE
Am J Transplant; 2019 May; 19(5):1464-1477. PubMed ID: 30582269
[TBL] [Abstract][Full Text] [Related]
29. Preoperative recipient cytokine levels are associated with early lung allograft dysfunction.
Allen JG; Lee MT; Weiss ES; Arnaoutakis GJ; Shah AS; Detrick B
Ann Thorac Surg; 2012 Jun; 93(6):1843-9. PubMed ID: 22503850
[TBL] [Abstract][Full Text] [Related]
30. Recipient and surgical factors trigger severe primary graft dysfunction after heart transplant.
Benck L; Kransdorf EP; Emerson DA; Rushakoff J; Kittleson MM; Klapper EB; Megna DJ; Esmailian F; Halprin C; Trento A; Ramzy D; Czer LSC; Chang DH; Ebinger JE; Kobashigawa JA; Patel JK
J Heart Lung Transplant; 2021 Sep; 40(9):970-980. PubMed ID: 34272125
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial DNA Stimulates TLR9-Dependent Neutrophil Extracellular Trap Formation in Primary Graft Dysfunction.
Mallavia B; Liu F; Lefrançais E; Cleary SJ; Kwaan N; Tian JJ; Magnen M; Sayah DM; Soong A; Chen J; Saggar R; Shino MY; Ross DJ; Derhovanessian A; Lynch JP; Ardehali A; Weigt SS; Belperio JA; Hays SR; Golden JA; Leard LE; Shah RJ; Kleinhenz ME; Venado A; Kukreja J; Singer JP; Looney MR
Am J Respir Cell Mol Biol; 2020 Mar; 62(3):364-372. PubMed ID: 31647878
[TBL] [Abstract][Full Text] [Related]
32. Primary Graft Dysfunction in Lung Transplantation: A Review of Mechanisms and Future Applications.
Chacon-Alberty L; Fernandez R; Jindra P; King M; Rosas I; Hochman-Mendez C; Loor G
Transplantation; 2023 Aug; 107(8):1687-1697. PubMed ID: 36650643
[TBL] [Abstract][Full Text] [Related]
33. The contribution of airway and lung tissue ischemia to primary graft dysfunction.
Diamond JM; Christie JD
Curr Opin Organ Transplant; 2010 Oct; 15(5):552-7. PubMed ID: 20693898
[TBL] [Abstract][Full Text] [Related]
34. The Perioperative Lung Transplant Virome: Torque Teno Viruses Are Elevated in Donor Lungs and Show Divergent Dynamics in Primary Graft Dysfunction.
Abbas AA; Diamond JM; Chehoud C; Chang B; Kotzin JJ; Young JC; Imai I; Haas AR; Cantu E; Lederer DJ; Meyer KC; Milewski RK; Olthoff KM; Shaked A; Christie JD; Bushman FD; Collman RG
Am J Transplant; 2017 May; 17(5):1313-1324. PubMed ID: 27731934
[TBL] [Abstract][Full Text] [Related]
35. The association of post-lung transplant acute kidney injury with mortality is independent of primary graft dysfunction: A cohort study.
Shashaty MGS; Forker CM; Miano TA; Wu Q; Yang W; Oyster ML; Porteous MK; Cantu EE; Diamond JM; Christie JD
Clin Transplant; 2019 Oct; 33(10):e13678. PubMed ID: 31355953
[TBL] [Abstract][Full Text] [Related]
36. A Focused Review on Primary Graft Dysfunction after Clinical Lung Transplantation: A Multilevel Syndrome.
Van Slambrouck J; Van Raemdonck D; Vos R; Vanluyten C; Vanstapel A; Prisciandaro E; Willems L; Orlitová M; Kaes J; Jin X; Jansen Y; Verleden GM; Neyrinck AP; Vanaudenaerde BM; Ceulemans LJ
Cells; 2022 Feb; 11(4):. PubMed ID: 35203392
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-17 receptor polymorphism predisposes to primary graft dysfunction after lung transplantation.
Somers J; Ruttens D; Verleden SE; Vandermeulen E; Piloni D; Wauters E; Lambrechts D; Vos R; Verleden GM; Vanaudenaerde B; van Raemdonck DE
J Heart Lung Transplant; 2015 Jul; 34(7):941-9. PubMed ID: 25935436
[TBL] [Abstract][Full Text] [Related]
38. Lung Innate Lymphoid Cell Composition Is Altered in Primary Graft Dysfunction.
Monticelli LA; Diamond JM; Saenz SA; Tait Wojno ED; Porteous MK; Cantu E; Artis D; Christie JD
Am J Respir Crit Care Med; 2020 Jan; 201(1):63-72. PubMed ID: 31394048
[No Abstract] [Full Text] [Related]
39. Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation.
Sayah DM; Mallavia B; Liu F; Ortiz-Muñoz G; Caudrillier A; DerHovanessian A; Ross DJ; Lynch JP; Saggar R; Ardehali A; ; Ware LB; Christie JD; Belperio JA; Looney MR
Am J Respir Crit Care Med; 2015 Feb; 191(4):455-63. PubMed ID: 25485813
[TBL] [Abstract][Full Text] [Related]
40. A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation.
Shah RJ; Bellamy SL; Localio AR; Wickersham N; Diamond JM; Weinacker A; Lama VN; Bhorade S; Belperio JA; Crespo M; Demissie E; Kawut SM; Wille KM; Lederer DJ; Lee JC; Palmer SM; Orens J; Reynolds J; Shah A; Wilkes DS; Ware LB; Christie JD
J Heart Lung Transplant; 2012 Sep; 31(9):942-9. PubMed ID: 22694851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
